A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

DSpace Repository

A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

Author: Metzenmacher, Martin; Kopp, Hans-Georg; Griesinger, Frank; Reinmuth, Niels; Sebastian, Martin; Serke, Monika; Waller, Cornelius Florian; Thomas, Michael; Eggert, Jochen; Schmid-Bindert, Gerald; Hoiczyk, Mathias; Christoph, Daniel Christian; Kimmich, Martin; Deuss, Burkhard; Seifert, Stephanie; Held, Swantje; Schuler, Martin; Herold, Thomas; Breitenbuecher, Frank; Eberhardt, Wilfried Ernst Erich
Tübinger Autor(en):
Kopp, Hans-Georg
Kimmich, Martin
Published in: Therapeutic Advances in Medical Oncology (2021), Bd. 13, Article 1758835921996506
Verlagsangabe: Sage Publications Ltd
Language: English
Full text: http://dx.doi.org/10.1177/1758835921996506
ISSN: 1758-8359
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)